The emerging mycotoxin, enniatin B1, down-modulates the gastrointestinal toxicity of T-2 toxin in vitro on intestinal epithelial cells and ex vivo on intestinal explants

Archives of Toxicology

Volumn 87, Issue 12, 2013, Pages 2233-2241

  Kolf Clauw, Martine ^a   Sassahara, Marcia ^a   Lucioli, Joelma ^a   Rubira Gerez, Juliana ^a   Alassane Kpembi, Imourana ^a   Lyazhri, Faouzi ^b   Borin, Christiane ^a,c   Oswald, Isabelle P ^a  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Combination index; Emerging mycotoxins; Enniatins; Gastrointestinal toxicity; Interactions; Jejunal explants

Indexed keywords

ENNIATIN; ENNIATIN B1; MYCOTOXIN; T 2 TOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EX VIVO STUDY; FOOD SAFETY; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; IC 50; IN VITRO STUDY; INTESTINE EPITHELIUM; NONHUMAN; NONLINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL;

FUSARIUM; SUIDAE;

ANIMALS; ANIMALS, NEWBORN; CELL PROLIFERATION; CELLS, CULTURED; DATA INTERPRETATION, STATISTICAL; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EPITHELIAL CELLS; GASTROINTESTINAL DISEASES; INTESTINAL MUCOSA; JEJUNUM; MYCOTOXINS; ORGAN CULTURE TECHNIQUES; SWINE; T-2 TOXIN;

EID: 84890558031     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-013-1067-8     Document Type: Article

References (37)

1. Behm C, Degen GH, Föllmann W (2009) The Fusarium toxin enniatin B exerts no genotoxic activity, but pronounced cytotoxicity in vitro. Mol Nutr Food Res 53:423-430
2. Behm C, Föllmann W, Degen GH (2012) Cytotoxic Potency of Mycotoxins in Cultures of V79 Lung Fibroblast Cells. J Toxicol Environ Health Part A 75:1226-1231
3. Berenbaum MC (1985) The expected effect of a combination of agents: the general solution. J Theor Biol 114:413-431
4. Borgert CJ, Price B, Wells CS (2001) Evaluating chemical interaction studies for mixture risk assessment. Hum Ecol Risk Assess 7:259-306
5. Bosch U, Mirocha CJ, Abbas HK, di Menna M (1989) Toxicity and toxin production by Fusarium isolates from New Zealand. Mycopathologia 108:73-79
6. Bouhet S, Le Dorze E, Pérès SY, Fairbrother JM, Oswald IP (2006) Mycotoxin fumonisin B1 selectively down-regulates the basal IL-8 expression in pig intestine: in vivo and in vitro studies. Food Chem Toxicol 44:1768-1773
7. Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621-681
8. Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27-55
9. Doi K, Shinozuka J, Sehata S (2006) T-2 toxin and apoptosis. J Toxicol Pathol 19:15-27
10. EFSA (2011) Scientific Opinion on the risks for animal and public health related to the presence of T-2 and HT-2 toxin in food and feed. EFSA J 9:1-187
11. Föllmann W, Behm C, Degen GH (2009) The emerging Fusarium toxin enniatin B: in vitro studies on its genotoxic potential and cytotoxicity in V79 cells in relation to other mycotoxins. Mycotoxin Res 25:11-19
12. Gammelsrud A, Solhaug A, Dendelé B, Sandberg WJ, Ivanova L, Kocbach Bølling A, Lagadic-Gossmann D, Refsnes M, Becher R, Eriksen G, Holme JA (2012) Enniatin B-induced cell death and inflammatory responses in RAW 267.4 murine macrophages. Toxicol Appl Pharmacol 261:74-87
13. Gaümann E, Naef-Roth S, Ettlinger L (1950) Zur Gewinnung von enniatinen aus dem myzel verschiedener fusarien. Phytopathol Z 16:289-299
14. Hymery N, Sibiril Y, Parent-Massin D (2006) In vitro effects of trichothecenes on human dendritic cells. Toxicol In Vitro 20:899-909
15. Ivanova L, Skjerve E, Eriksen GS, Uhlig S (2006) Cytotoxicity of enniatins A, A1, B, B1, B2 and B3 from Fusarium avenaceum. Toxicon 47:868-876
16. Ivanova L, Uhlig S, Eriksen GS, Johannessen LE (2010) Enniatin B1 is a substrate of intestinal P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein. World Mycotoxin J 3:271-281
17. Ivanova L, Egge-Jacobsen WM, Solhaug A, Thoen E, Fæste CK (2012) Lysosomes as a possible target of enniatin B-induced toxicity in Caco-2 cells. Chem Res Toxicol 25:1662-1674
18. Jestoi M (2008) Emerging fusarium-mycotoxins fusaprofilin, beauvericin, enniatins, and moniliformin: a review. Crit Rev Food Sci Nutr 48:21-49
19. Kolf-Clauw M, Castellote J, Joly B, Bourges-Abella N, Raymond-Letron I, Pinton P, et al (2009) Development of a pig jejunal explant culture for studying the gastrointestinal toxicity of the mycotoxin deoxynivalenol: histopathological analysis. Toxicol In Vitro 23:1580-1584
20. Li G, Shinozuka J, Uetsuka K, Nakayama H, Doi K (1997) T-2 toxin-induced apoptosis in intestinal crypt epithelial cells of mice. Exp Toxicol Pathol. 49:447-50
21. 1 by evaluation of duodenal and colonic bioavailability applying an in vitro method by Caco-2 cells. Toxicon 59:1-11
22. Pinton P, Nougayrède JP, Del Rio JC, Moreno C, Marin DE, Ferrier L, Bracarense AP, Kolf-Clauw M, Oswald IP (2009) The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol 237:41-48
23. Pinton P, Guzylack-Piriou L, Kolf-Clauw M, Oswald IP (2012a) Effects of some fungal toxins, the trichothecenes, on the intestine. Curr Immunol Rev 8:193-208
24. Pinton P, Tsybulskyy D, Lucioli J, Laffitte J, Callu P, Lyazhri F, Grosjean F, Bracarense AP, Kolf-Clauw M, Oswald IP (2012b) Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junctions proteins and MAPKinases. J Toxicol Sci 130:180-190
25. Rodrigues I, Naehrer K (2012) A three-year survey on the worldwide occurrence of mycotoxins in feedstuffs and feed. Toxins 4:663-675
26. Ruiz MJ, Franzova P, Juan-Garcia A, Font G (2011a) Toxicological interactions between the mycotoxins beauvericin, deoxynivalenol and t-2 toxin in cho-k1 cells in vitro. Toxicon 58:315-326
27. Ruiz MJ, Macakova P, Juan-Garcia A, Font G (2011b) Cytotoxic effects of mycotoxin combinations in mammalian kidney cells. Food Chem Toxicol 49:2718-2724
28. Santini A, Meca G, Uhlig S, Ritieni A (2012) Fusaproliferin, beauvericin and enniatins: occurrence in food - a review. World Mycotoxin J 5:71-81
29. Serrano AB, Font G, Mañes J, Ferrer E (2013) Emerging Fusarium mycotoxins in organic and conventional pasta collected in Spain. Food Chem Toxicol 51:259-266
30. Streit E, Schwab C, Sulyok M, Naehrer K, Krska R, Schatzmayr G (2013) Multi-Mycotoxin Screening Reveals the Occurrence of 139 Different Secondary Metabolites in Feed and Feed Ingredients. Toxins 5:504-523
31. Tallarida RJ (2006) An overview of drug combination analysis with isobolograms. J Pharmacol Experiment Therapeutics 319:1-7
32. Tedjiotsop Feudjio F, Dornetshuber R, Lemmens M, Hoffmann O, Lemmens-Gruber R, Berger W (2010) Beauvericin and enniatin: emerging toxins and/or remedies? World Mycotoxin J 3:415-430
33. Uhlig S, Torp M, Heier BT (2006) Beauvericin and enniatins A, A1, B and B1 in Norwegian grain: a survey. Food Chem 94:193-201
34. Van der Fels-Klerx HJ, Stratakou I (2010) T-2 toxin and HT-2 toxin in grain and grain-based commodities in Europe: occurrence, factors affecting occurrence, co-occurrence and toxicological effects. World Mycotoxin J 3:349-367
35. Van Der Fels-Klerx HJ, Klemsdal S, Hietaniemi V, Lindblad M, Ioannou-Kakouri E, Van Asselt ED (2012) Mycotoxin contamination of cereal grain commodities in relation to climate in North West Europe. Food Addit Contam A 29:1581-1592
36. Wätjen W, Debbab A, Hohlfeld A, Chovolou Y, Kampkötter A, Edrada RA, Ebel R, Hakiki A, Mosaddak M, Totzke F, Kubbutat MH (2009) Enniatins A1, B and B1 from an endophytic strain of Fusarium tricinctum induce apoptotic cell death in H4IIE hepatoma cells accompanied by inhibition of ERK phosphorylation. Mol Nutr Food Res 53(431):440
37. Yang GH, Jarvis BB, Chung YJ, Pestka JJ (2000) Apoptosis induction by satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation. Toxicol Appl Pharmacol 164:149-160